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ABSTRACT 
 
 
Malaria is still a major health problem, killing approximately 1,600 people 
each day. The most vulnerable patient groups are children under the age of 
five and pregnant women. Artemisinin-based combination therapy is 
recommended by the World Health Organization as first-line treatment of 
uncomplicated P. falciparum malaria. The aim of this thesis was to 
investigate the pharmacokinetic properties of artemisinin derivatives with 
particular focus on pregnancy. As part of the thesis, a sensitive and 
accurate bioanalytical method for the quantification of artesunate and 
dihydroartemisinin in plasma and saliva using tandem mass spectrometry 
was developed. Furthermore, the population pharmacokinetic properties of 
artemisinin, artesunate and dihydroartemisinin were characterized in 
pregnant and non-pregnant rats, healthy volunteers and in pregnant and 
non-pregnant patients, using nonlinear mixed-effects modelling. In 
conclusion, a bioanalytical method has been developed for non-invasive 
saliva sampling in order to support high-quality pharmacokinetic field 
studies and in populations where invasive sampling is unethical or 
difficult, e.g. pediatric and pregnant studies. Furthermore, this thesis 
advances our pharmacokinetic understanding of antimalarial drugs. The 
pharmacokinetic effects of pregnancy in rats were similar to those seen in 
humans which imply that this animal model could be useful in translational 
studies in early pregnancy. The developed pharmacokinetic model in 
healthy volunteers was validated and could be of use in future drug 
development studies. A lower antimalarial drug exposure was 
demonstrated in pregnant women with malaria indicating the need for dose 
adjustment in this vulnerable patient group.  
 
 
Keywords: malaria, artemisinin, artesunate, dihydroartemisinin, LC-MS/MS, pharmacometrics, 
pregnancy 
ISBN: 978-91-628-9531-0 
